{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:09:40Z","timestamp":1793722180081,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai shenkang Hospital Development Group Medical Enterprise Integration and Innovation Cooperation Special Projec"},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of Chin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB216093"],"award-info":[{"award-number":["20232BAB216093"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The RIG-I\/MAVS signaling stimulates anti-tumor immunity by triggering the production of inflammatory cytokines. Activation of MAVS induced by viral RNA and RIG-I binding is critical in this pathway. However, the molecular mechanism underlying the regulation of MAVS activity and its function in anti-tumor immunity is not fully understood. Here, we report that the ubiquitin-specific protease 35 (USP35) negatively regulates the MAVS signaling. Mechanistically, USP35 interacts with MAVS and removes its K63-linked polyubiquitin chains, thereby inhibiting viral-induced MAVS-TBK1-IRF3 activation and downstream inflammatory gene expression. Importantly, depletion of USP35 significantly enhances the anti-tumor immunity and synergizes with oncolytic virotherapy to suppress xenograft tumor growth of melanoma cells. Thus, our study identifies USP35 as a negative regulator of MAVS signaling, representing a potential immunosuppressive factor in cutaneous melanoma.<\/jats:p>","DOI":"10.1038\/s41419-025-07411-8","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:40:44Z","timestamp":1740728444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Deubiquitination enzyme USP35 negatively regulates MAVS signaling to inhibit anti-tumor immunity"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-7795","authenticated-orcid":false,"given":"Heping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengpeng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1755-3731","authenticated-orcid":false,"given":"Yu\u2019e","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-8593","authenticated-orcid":false,"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"7411_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA. Cutaneous melanoma. Lancet. 2023;402:485\u2013502.","journal-title":"Lancet"},{"key":"7411_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"7411_CR3","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","volume":"20","author":"LE Davis","year":"2019","unstructured":"Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20:1366\u201379.","journal-title":"Cancer Biol Ther"},{"key":"7411_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","volume":"20","author":"SZ Shalhout","year":"2023","unstructured":"Shalhout SZ, Miller DM, Emerick KS, Kaufman HL. Therapy with oncolytic viruses: progress and challenges. Nat Rev Clin Oncol. 2023;20:160\u201377.","journal-title":"Nat Rev Clin Oncol"},{"key":"7411_CR5","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/cdd.2014.96","volume":"21","author":"P Duewell","year":"2014","unstructured":"Duewell P, Steger A, Lohr H, Bourhis H, Hoelz H, Kirchleitner SV, et al. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells. Cell Death Differ. 2014;21:1825\u201337.","journal-title":"Cell Death Differ"},{"key":"7411_CR6","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/nm.1887","volume":"14","author":"H Poeck","year":"2008","unstructured":"Poeck H, Besch R, Maihoefer C, Renn M, Tormo D, Morskaya SS, et al. 5\u2019-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat Med. 2008;14:1256\u201363.","journal-title":"Nat Med"},{"key":"7411_CR7","doi-asserted-by":"publisher","first-page":"eaau8943","DOI":"10.1126\/sciimmunol.aau8943","volume":"4","author":"S Heidegger","year":"2019","unstructured":"Heidegger S, Wintges A, Stritzke F, Bek S, Steiger K, Koenig PA, et al. RIG-I activation is critical for responsiveness to checkpoint blockade. Sci Immunol. 2019;4:eaau8943.","journal-title":"Sci Immunol"},{"key":"7411_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.coi.2011.08.001","volume":"23","author":"SM Belgnaoui","year":"2011","unstructured":"Belgnaoui SM, Paz S, Hiscott J. Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol. 2011;23:564\u201372.","journal-title":"Curr Opin Immunol"},{"key":"7411_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-981-13-9367-9_8","volume":"1172","author":"X Fan","year":"2019","unstructured":"Fan X, Jin T. Structures of RIG-I-like receptors and insights into Viral RNA sensing. Adv Exp Med Biol. 2019;1172:157\u201388.","journal-title":"Adv Exp Med Biol"},{"key":"7411_CR10","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1016\/j.jmb.2013.10.007","volume":"425","author":"JL Jacobs","year":"2013","unstructured":"Jacobs JL, Coyne CB. Mechanisms of MAVS regulation at the mitochondrial membrane. J Mol Biol. 2013;425:5009\u201319.","journal-title":"J Mol Biol"},{"key":"7411_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/eji.201646484","volume":"47","author":"KM Quicke","year":"2017","unstructured":"Quicke KM, Diamond MS, Suthar MS. Negative regulators of the RIG-I-like receptor signaling pathway. Eur J Immunol. 2017;47:615\u201328.","journal-title":"Eur J Immunol"},{"key":"7411_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ni.3641","volume":"18","author":"B Liu","year":"2017","unstructured":"Liu B, Zhang M, Chu H, Zhang H, Wu H, Song G, et al. The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination. Nat Immunol. 2017;18:214\u201324.","journal-title":"Nat Immunol"},{"key":"7411_CR13","doi-asserted-by":"publisher","first-page":"e00321","DOI":"10.1128\/JVI.00321-18","volume":"92","author":"B Xue","year":"2018","unstructured":"Xue B, Li H, Guo M, Wang J, Xu Y, Zou X, et al. TRIM21 promotes innate immune response to RNA viral infection through Lys27-linked polyubiquitination of MAVS. J Virol. 2018;92:e00321\u201318.","journal-title":"J Virol"},{"key":"7411_CR14","first-page":"573","volume":"46","author":"YJ Kim","year":"2023","unstructured":"Kim YJ, Lee Y, Shin H, Hwang S, Park J, Song EJ. Ubiquitin-proteasome system as a target for anticancer treatment-an update. ArchPharmacal Res. 2023;46:573\u201397.","journal-title":"ArchPharmacal Res"},{"key":"7411_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/15548627.2015.1034408","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang Y, Serricchio M, Jauregui M, Shanbhag R, Stoltz T, Di Paolo CT, et al. Deubiquitinating enzymes regulate PARK2-mediated mitophagy. Autophagy. 2015;11:595\u2013606.","journal-title":"Autophagy"},{"key":"7411_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.390","volume":"11","author":"Z Tang","year":"2021","unstructured":"Tang Z, Jiang W, Mao M, Zhao J, Chen J, Cheng N. Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin. Clin Transl Med. 2021;11:e390.","journal-title":"Clin Transl Med"},{"key":"7411_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41418-020-0588-y","volume":"28","author":"J Zhang","year":"2021","unstructured":"Zhang J, Chen Y, Chen X, Zhang W, Zhao L, Weng L, et al. Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer. Cell Death Differ. 2021;28:139\u201355.","journal-title":"Cell Death Differ"},{"key":"7411_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20161387","volume":"214","author":"Y Chen","year":"2017","unstructured":"Chen Y, Wang L, Jin J, Luan Y, Chen C, Li Y, et al. p38 inhibition provides anti-DNA virus immunity by regulation of USP21 phosphorylation and STING activation. J Exp Med. 2017;214:991\u20131010.","journal-title":"J Exp Med"},{"key":"7411_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cytogfr.2016.02.010","volume":"29","author":"K Blaszczyk","year":"2016","unstructured":"Blaszczyk K, Nowicka H, Kostyrko K, Antonczyk A, Wesoly J, Bluyssen HA. The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses. Cytokine growth factor Rev. 2016;29:71\u201381.","journal-title":"Cytokine growth factor Rev"},{"key":"7411_CR20","doi-asserted-by":"publisher","first-page":"12067","DOI":"10.1073\/pnas.0900971106","volume":"106","author":"A Schmidt","year":"2009","unstructured":"Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, Wenzel M, et al. 5\u2019-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci USA. 2009;106:12067\u201372.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7411_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41422-018-0107-6","volume":"29","author":"T Liuyu","year":"2019","unstructured":"Liuyu T, Yu K, Ye L, Zhang Z, Zhang M, Ren Y, et al. Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS. Cell Res. 2019;29:67\u201379.","journal-title":"Cell Res"},{"key":"7411_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.immuni.2016.04.002","volume":"44","author":"A Roers","year":"2016","unstructured":"Roers A, Hiller B, Hornung V. Recognition of endogenous nucleic acids by the innate immune system. Immunity. 2016;44:739\u201354.","journal-title":"Immunity"},{"key":"7411_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02557-21","volume":"12","author":"N Berry","year":"2021","unstructured":"Berry N, Susp\u00e8ne R, Caval V, Khalfi P, Beauclair G, Rigaud S, et al. Herpes simplex virus type 1 infection disturbs the mitochondrial network, leading to type i interferon production through the RNA polymerase III\/RIG-I pathway. mBio. 2021;12:e0255721.","journal-title":"mBio"},{"key":"7411_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ymthe.2018.11.010","volume":"27","author":"G Shi","year":"2019","unstructured":"Shi G, Yang Q, Zhang Y, Jiang Q, Lin Y, Yang S, et al. Modulating the tumor microenvironment via oncolytic viruses and CSF-1R inhibition synergistically enhances anti-PD-1 immunotherapy. Mol Ther. 2019;27:244\u201360.","journal-title":"Mol Ther"},{"key":"7411_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.07.004","volume":"66","author":"P Allavena","year":"2008","unstructured":"Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol\/Hematol. 2008;66:1\u20139.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"7411_CR26","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/cells9051175","volume":"9","author":"MC Nielsen","year":"2020","unstructured":"Nielsen MC, Hvidbjerg Gantzel R, Cl\u00e0ria J, Trebicka J, M\u00f8ller HJ, Gr\u00f8nb\u00e6k H. Macrophage activation markers, CD163 and CD206, in acute-on-chronic liver failure. Cells. 2020;9:1175.","journal-title":"Cells"},{"key":"7411_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-immunol-032713-120156","volume":"32","author":"J Wu","year":"2014","unstructured":"Wu J, Chen ZJ. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol. 2014;32:461\u201388.","journal-title":"Annu Rev Immunol"},{"key":"7411_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1087-y","volume":"18","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, An X, Zhang X, Qiao Y, Zheng T, Li X. STING: a master regulator in the cancer-immunity cycle. Mol Cancer. 2019;18:152.","journal-title":"Mol Cancer"},{"key":"7411_CR29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12964-020-00659-x","volume":"18","author":"Y Song","year":"2020","unstructured":"Song Y, Zhou Y, Zhou X. The role of mitophagy in innate immune responses triggered by mitochondrial stress. Cell Commun Signal. 2020;18:186.","journal-title":"Cell Commun Signal"},{"key":"7411_CR30","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019103285","volume":"39","author":"X Liu","year":"2020","unstructured":"Liu X, Zhu C, Zha H, Tang J, Rong F, Chen X, et al. SIRT5 impairs aggregation and activation of the signaling adaptor MAVS through catalyzing lysine desuccinylation. EMBO J. 2020;39:e103285.","journal-title":"EMBO J"},{"key":"7411_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23219-4","volume":"12","author":"J Hou","year":"2021","unstructured":"Hou J, Han L, Zhao Z, Liu H, Zhang L, Ma C, et al. USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS. Nat Commun. 2021;12:2970.","journal-title":"Nat Commun"},{"key":"7411_CR32","doi-asserted-by":"publisher","first-page":"7540","DOI":"10.4049\/jimmunol.178.12.7540","volume":"178","author":"JB Swann","year":"2007","unstructured":"Swann JB, Hayakawa Y, Zerafa N, Sheehan KC, Scott B, Schreiber RD, et al. Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J Immunol. 2007;178:7540\u20139.","journal-title":"J Immunol"},{"key":"7411_CR33","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1084\/jem.20101158","volume":"208","author":"MS Diamond","year":"2011","unstructured":"Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med. 2011;208:1989\u20132003.","journal-title":"J Exp Med"},{"key":"7411_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-023-01405-9","volume":"16","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhang H, Wang J, Chen J, Guo Z, Liu Y, et al. Exploiting RIG-I-like receptor pathway for cancer immunotherapy. J Hematol Oncol. 2023;16:8.","journal-title":"J Hematol Oncol"},{"key":"7411_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12032-014-0095-4","volume":"31","author":"J Dong","year":"2014","unstructured":"Dong J, Li W, Dong A, Mao S, Shen L, Li S, et al. Gene therapy for unresectable hepatocellular carcinoma using recombinant human adenovirus type 5. Med Oncol. 2014;31:95.","journal-title":"Med Oncol"},{"key":"7411_CR36","first-page":"527","volume":"35","author":"R Chanut","year":"2019","unstructured":"Chanut R, Petrilli V. [Cytosolic DNA sensing by the cGAS-STING pathway in cancer]. Med Sci. 2019;35:527\u201334.","journal-title":"Med Sci"},{"key":"7411_CR37","doi-asserted-by":"publisher","first-page":"17870","DOI":"10.1073\/pnas.0909545106","volume":"106","author":"MK Choi","year":"2009","unstructured":"Choi MK, Wang Z, Ban T, Yanai H, Lu Y, Koshiba R, et al. A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA. Proc Natl Acad Sci USA. 2009;106:17870\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7411_CR38","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.2147\/JIR.S362619","volume":"15","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Liu YJ, Li JP, Zeng SH, Shen H, Han M, et al. USP35 is a potential immunosuppressive factor in skin cutaneous melanoma. J Inflamm Res. 2022;15:3065\u201382.","journal-title":"J Inflamm Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07411-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07411-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07411-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:40:51Z","timestamp":1740728451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07411-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7411"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07411-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All cellular experiments were approved by the Ethics Committee of Shanghai Tenth People\u2019s Hospital (approval number 2021KN108).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Cell ethics"}},{"value":"Animal handling and experimental procedures were approved by the Institutional Animal Care and Use Committee at Shanghai Tenth People\u2019s Hospital, Tongji University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal ethics"}}],"article-number":"138"}}